Xencor, Inc. has grown revenue −2.5% a year over three years and −10% a year over five. Revenue growth, 3-year annual rate: −2.5% (Biotechnology median +17%). Revenue growth, 5-year rate: −10%, growth has picked up over the last three years. Years of annual history on file: 14, FY2012 to FY2025, as filed.

XNCRXencor, Inc.

Healthcare

$24.63+139% 1Y

$24.63

$10.3252 weeks$29.30

Is it growing?

Watch

Growth is fading: revenue shrinking (−29% year on year) and operating margin narrowing (−417.4 points).

2 to watch, 1 without data

Revenue trend−29% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −10% a year.

Margin direction−417.4 points operating

Trailing-twelve-month operating margin, -553.2% now against -135.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is XNCR growing?

Xencor, Inc. has grown revenue −2.5% a year over three years and −10% a year over five.

−2.5%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −10%
Revenue growth, 5-year rate · −2.5% over three · growth has picked up over the last three years
Years of annual history on file: 14
Years of annual history on file · FY2012 to FY2025, as filed

Details›